Cytotherapy publication 2026

Our latest Cytotherapy publication explores barriers limiting CAR-T access in Europe and highlights how the EASYGEN framework and decentralised manufacturing can help.

The first peer-reviewed EASYGEN consortium perspective examines the barriers limiting CAR-T access in Europe and the potential role of decentralised manufacturing, automation and non-viral gene engineering in addressing them.

For further insights, read the full publication : https://doi.org/10.1016/j.jcyt.2026.102939

‍

This project has received funding from the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101194710. The JU receives support from the European Union’s Horizon Europe research and innovation programme and EFPIA. — Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.